» » Vaccines: Frontiers in Design and Development

Download Vaccines: Frontiers in Design and Development fb2

by Phillipe Moingeon

Download Vaccines: Frontiers in Design and Development fb2
Author: Phillipe Moingeon
ISBN: 1904933092
Language: English
Pages: 330 pages
Category: Biological Sciences
Publisher: Taylor & Francis; 1 edition (June 6, 2005)
Rating: 4.9
Formats: lit txt azw docx
FB2 size: 1944 kb | EPUB size: 1224 kb | DJVU size: 1821 kb
Sub: Math

2. Immunological Basis for the Rational Design of New Vaccines. 3. Targeting Innate Immunity With Adjuvants: Can Accurate Danger Signals Drive More Protective Immune Responses?

Taylor & Francis Published April 21, 2005 Reference - 330 Pages - 16 B/W Illustrations ISBN 9781904933090 - CAT RU39925. 2. Targeting Innate Immunity With Adjuvants: Can Accurate Danger Signals Drive More Protective Immune Responses? 4. Mucosal Immunity and Vaccine Design. 5. Immunization Using the Skin: New Approaches. 6. Cellular Vaccines: Current Status. 7. Veterinary Applications of the Canarypox Vaccine Vector Technology: Recent Developments for Vaccines in Domestic Mammalian Species.

Duncan Steele, Roger Glass and Joseph Bresee. Chapter 12 Development of Vaccines Against Human.

Chapter 2 Immunological Basis for the Rational Design of. New Vaccines. 19. Laleh Majlessi and Claude Leclerc. Chapter 3 Targeting Innate Immunity With Adjuvants: Can Accurate Danger Signals Drive More Protective. Duncan Steele, Roger Glass and Joseph Bresee. 207. Russell L. Basser, Stirling Edwards and. Ian . razer. Chapter 13 Development of Cancer Vaccines: Current Status 231. Pamela L. Beatty and Olivera J. Finn.

Since variolation, conventional approaches to vaccine development are based on live-attenuated, inactivated or purified pathogen-derived components. However, effective vaccines against global health threats such as HIV, parasite infections and tumors are difficult to achieve

Since variolation, conventional approaches to vaccine development are based on live-attenuated, inactivated or purified pathogen-derived components. However, effective vaccines against global health threats such as HIV, parasite infections and tumors are difficult to achieve. On the other hand, synthetic vaccines based on immunogenic epitopes offer advantages over traditional vaccines since they are chemically defined antigens free from deleterious effects

1. Driving Forces in the Development of Innovative Vaccines.

Taylor & Francis. 330 pages 16 B/W Illus. Topics covered include the immunological basis for rational design of new vaccines, targeting the innate immune system, mucosal immunity, vaccine safety, and vaccine vector technology. 1.

Topics covered include the immunological basis for rational design of new vaccines, targeting the innate immune system, mucosal immunity, vaccine safety, and vaccine vector technology.

Are you sure you want to remove VACCINES: FRONTIERS IN DESIGN AND DEVELOPMENT; ED. BY PHILIPPE MOINGEON. from your list? Vaccines: frontiers in design and development; ED. Published by HORIZON BIOSCIENCE in NORFOLK. Written in Undetermined.

Most investigations aiming to identify biomarkers (BMKs) have focused on immunological changes reflecting our understanding of allergen-specific immunotherapy (AIT) mechanisms of action.

It was established in 1996 and covers all biological and medical sciences.

Authors: Philippe Moingeon. Expert Rev Vaccines 2014 Dec 4;13(12):1463-73. Download full-text PDF. Source.

Generations of new vaccines such as DNA-based vaccines, multipeptide, lipopeptide, molecular, cellular and replicon-based vaccines are currently being developed to help combat viral, bacterial, and parasitic infections, and non-infectious diseases including cancer, autoimmune diseases, allergies, neurodegenerative and metabolic diseases.In this book internationally acclaimed authors review current strategies and approaches in vaccine development. Topics covered include the immunological basis for rational design of new vaccines, targeting the innate immune system, mucosal immunity, vaccine safety, and vaccine vector technology. Several chapters are devoted to the development of vaccines to combat specific diseases such as tuberculosis, nosocomal infections, rotaviruses, human papillomavirus, cancer, and allergies.